Prime Medicine, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ALPHABET INC. | 11/07/2025 | 16.56 M | $91.76 M | 9.96% | 12.82% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 9.22 M | $51.06 M | 42.13% | 7.13% |
| BLACKROCK, INC. | 11/12/2025 | 5.65 M | $31.31 M | 25.97% | 4.37% |
| ARK INVESTMENT MANAGEMENT LLC | 11/12/2025 | 5.48 M | $30.35 M | 135.84% | 4.24% |
| VANGUARD GROUP INC | 11/07/2025 | 4.92 M | $27.27 M | 35.68% | 3.81% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 4.75 M | $26.32 M | 533.33% | 3.68% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 10/27/2025 | 3.63 M | $20.11 M | 127.65% | 2.81% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/12/2025 | 3.63 M | $20.04 M | 128.42% | 2.81% |
| CASDIN CAPITAL, LLC | 11/14/2025 | 3.17 M | $17.55 M | 102.09% | 2.45% |
| WOODLINE PARTNERS LP | 11/14/2025 | 3.00 M | $16.63 M | 100.00% | 2.32% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 3.00 M | $16.62 M | 100.00% | 2.32% |
| FMR LLC | 11/13/2025 | 2.81 M | $15.58 M | -24.87% | 2.18% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 2.22 M | $12.28 M | 100.00% | 1.72% |
| MWG MANAGEMENT LTD. | 11/12/2025 | 1.79 M | $9.93 M | 0.00% | 1.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.77 M | $9.79 M | 16.96% | 1.37% |
| ECOR1 CAPITAL, LLC | 11/14/2025 | 1.54 M | $8.55 M | 100.00% | 1.19% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.42 M | $7.86 M | 858.45% | 1.10% |
| STATE STREET CORP | 11/14/2025 | 1.30 M | $7.18 M | 4.62% | 1.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 1.13 M | $6.29 M | 407.91% | 0.88% |
| CITADEL ADVISORS LLC | 11/14/2025 | 900.14 K | $4.99 M | 72.60% | 0.70% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 771.36 K | $4.27 M | 100.00% | 0.60% |
| INVESCO LTD. | 11/13/2025 | 762.08 K | $4.22 M | 5,478.09% | 0.59% |
| MORGAN STANLEY | 11/14/2025 | 731.00 K | $4.05 M | 24.39% | 0.57% |
| GREENWICH WEALTH MANAGEMENT LLC | 11/12/2025 | 720.00 K | $3.99 M | -14.91% | 0.56% |
| NORTHERN TRUST CORP | 11/14/2025 | 607.99 K | $3.37 M | 18.69% | 0.47% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 593.04 K | $3.29 M | -27.55% | 0.46% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 584.42 K | $3.24 M | 21.07% | 0.45% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 573.16 K | $3.18 M | 10.51% | 0.44% |
| MOORE CAPITAL MANAGEMENT, LP | 11/14/2025 | 500.00 K | $2.77 M | 0.00% | 0.39% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 447.67 K | $2.48 M | 73.23% | 0.35% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 414.21 K | $2.29 M | -2.39% | 0.32% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 410.74 K | $2.28 M | 98.42% | 0.32% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 399.50 K | $2.21 M | 368.90% | 0.31% |
| BOLLARD GROUP LLC | 11/14/2025 | 361.14 K | $2.00 M | 0.00% | 0.28% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 333.76 K | $1.85 M | 1,462.96% | 0.26% |
| UBS GROUP AG | 11/13/2025 | 304.77 K | $1.69 M | 56.03% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 268.80 K | $1.49 M | 541.53% | 0.21% |
| PEAK6 LLC | 11/14/2025 | 253.40 K | $1.40 M | 100.00% | 0.20% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 250.00 K | $1.39 M | 100.00% | 0.19% |
| NUVEEN, LLC | 11/12/2025 | 225.84 K | $1.25 M | 8.63% | 0.17% |
| HRT FINANCIAL LP | 11/14/2025 | 221.46 K | $1.23 M | 245.14% | 0.17% |
| CHELSEA COUNSEL CO | 11/25/2025 | 208.21 K | $1.15 M | 0.00% | 0.16% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 205.33 K | $1.14 M | 100.00% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 197.73 K | $1.10 M | 22.02% | 0.15% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 197.01 K | $1.09 M | 94.77% | 0.15% |
| CITADEL ADVISORS LLC | 11/14/2025 | 195.10 K | $1.08 M | 15.31% | 0.15% |
| GREEN ALPHA ADVISORS, LLC | 10/15/2025 | 190.35 K | $1.05 M | 140.97% | 0.15% |
| MAN GROUP PLC | 11/14/2025 | 189.59 K | $1.05 M | 100.00% | 0.15% |
| JBF CAPITAL, INC. | 11/14/2025 | 188.90 K | $1.05 M | 100.00% | 0.15% |
| DNB ASSET MANAGEMENT AS | 11/12/2025 | 182.13 K | $1.01 M | 100.00% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Prime Medicine, Inc. institutional Ownership - FAQ's
During the previous two years, 180 institutional investors and hedge funds held shares of Prime Medicine, Inc.. The most heavily invested institutionals were:
Alphabet Inc.: 16.56 M
T. Rowe Price Investment Management, Inc.: 9.22 M
BlackRock, Inc.: 5.65 M
ARK Investment Management LLC: 5.48 M
VANGUARD GROUP INC: 4.92 M
FARALLON CAPITAL MANAGEMENT LLC: 4.75 M
71.48% of Prime Medicine, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 97.92 M shares in the last 24 months. This purchase volume represents approximately $367.12 M in transactions.